Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health,Oncology
Reference17 articles.
1. Ferlay J, Soerjomataram I, Ervik M i wsp. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013.
http://globocan.iarc.fr
2. Wojciechowska U, Didkowska J, Zatoński W (2012) Nowotwory złośliwe w Polsce. Centrum Onkologii Instytut, Warszawa
3. De Angelis R, Sant M, wsp CMP i (2014) Cancer survival in europe 1999-2007 by country and age: results of EUROCARE–5-a population-based study. Lancet Oncol 15:23–34
4. Cunningam D, Pyrhonen S (1998) James RD i wsp. Randomised trial of irinotecan plus supportive care versus supportive care alone after flurouracil failure for patients with metastatic colorectal cancer. Lancet 352:1407–1412
5. Aranda E, Valladares M (2009) Martinez-Villacampa M i wsp. Randomized study of weekly irinotecan plus high-dose 5-fluorouracil (FUIRI) versus biweekly irinotecan plus 5-fluorouracil/leucovorin (FOLFIRI) as first-line chemotherapy for patients with metastatic colorectal cancer: a Spanish Cooperative Group for the Treatment of Digestive Tumors Study. Ann Oncol 20:251–257
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献